BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28889199)

  • 1. Oral delivery of staphylococcal nuclease by Lactococcus lactis prevents type 1 diabetes mellitus in NOD mice.
    Lang J; Wang X; Liu K; He D; Niu P; Cao R; Jin L; Wu J
    Appl Microbiol Biotechnol; 2017 Oct; 101(20):7653-7662. PubMed ID: 28889199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ameliorating gut microenvironment through staphylococcal nuclease-mediated intestinal NETs degradation for prevention of type 1 diabetes in NOD mice.
    Liang Y; Wang X; He D; You Q; Zhang T; Dong W; Fei J; Xing Y; Wu J
    Life Sci; 2019 Mar; 221():301-310. PubMed ID: 30776371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral delivery of staphylococcal nuclease ameliorates DSS induced ulcerative colitis in mice via degrading intestinal neutrophil extracellular traps.
    Dong W; Liu D; Zhang T; You Q; Huang F; Wu J
    Ecotoxicol Environ Saf; 2021 Jun; 215():112161. PubMed ID: 33812202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral administration of Lactococcus lactis-expressing heat shock protein 65 and tandemly repeated IA2P2 prevents type 1 diabetes in NOD mice.
    Liu KF; Liu XR; Li GL; Lu SP; Jin L; Wu J
    Immunol Lett; 2016 Jun; 174():28-36. PubMed ID: 27085380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant
    Preisser TM; da Cunha VP; Santana MP; Pereira VB; Cara DC; Souza BM; Miyoshi A
    J Diabetes Res; 2021; 2021():6697319. PubMed ID: 33604389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral administration of recombinant Lactococcus lactis expressing HSP65 and tandemly repeated P277 reduces the incidence of type I diabetes in non-obese diabetic mice.
    Ma Y; Liu J; Hou J; Dong Y; Lu Y; Jin L; Cao R; Li T; Wu J
    PLoS One; 2014; 9(8):e105701. PubMed ID: 25157497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulation therapy of diabetes by oral administration of a surfactin lipopeptide in NOD mice.
    Gao Z; Zhao X; Yang T; Shang J; Shang L; Mai H; Qi G
    Vaccine; 2014 Nov; 32(50):6812-9. PubMed ID: 25239487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of PAD4-mediated NET formation by cl-amidine prevents diabetes development in nonobese diabetic mice.
    Shen Y; You Q; Wu Y; Wu J
    Eur J Pharmacol; 2022 Feb; 916():174623. PubMed ID: 34767782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal Delivery of Proinsulin and IL-10 via
    Cook DP; Cunha JPMCM; Martens PJ; Sassi G; Mancarella F; Ventriglia G; Sebastiani G; Vanherwegen AS; Atkinson MA; Van Huynegem K; Steidler L; Caluwaerts S; Rottiers P; Teyton L; Dotta F; Gysemans C; Mathieu C
    Front Immunol; 2020; 11():1103. PubMed ID: 32582188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct screening of recombinants in gram-positive bacteria using the secreted staphylococcal nuclease as a reporter.
    Le Loir Y; Gruss A; Ehrlich SD; Langella P
    J Bacteriol; 1994 Aug; 176(16):5135-9. PubMed ID: 8051029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil-Associated Inflammatory Changes in the Pre-Diabetic Pancreas of Early-Age NOD Mice.
    Garciafigueroa Y; Phillips BE; Engman C; Trucco M; Giannoukakis N
    Front Endocrinol (Lausanne); 2021; 12():565981. PubMed ID: 33776903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil Extracellular Traps Induce Trypsin Activation, Inflammation, and Tissue Damage in Mice With Severe Acute Pancreatitis.
    Merza M; Hartman H; Rahman M; Hwaiz R; Zhang E; Renström E; Luo L; Mörgelin M; Regner S; Thorlacius H
    Gastroenterology; 2015 Dec; 149(7):1920-1931.e8. PubMed ID: 26302488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of human insulin in lactic acid bacteria and its oral administration in non-obese diabetic mice].
    Chen SW; Zhong J; Huan LD
    Wei Sheng Wu Xue Bao; 2007 Dec; 47(6):987-91. PubMed ID: 18271251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation.
    Martín R; Chain F; Miquel S; Natividad JM; Sokol H; Verdu EF; Langella P; Bermúdez-Humarán LG
    Hum Vaccin Immunother; 2014; 10(6):1611-21. PubMed ID: 24732667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Plasma miR-193b-365 Signature Combined With Age and Glycemic Status Predicts Response to Lactococcus lactis-Based Antigen-Specific Immunotherapy in New-Onset Type 1 Diabetes.
    Sassi G; Licata G; Ventriglia G; Wouters A; Lemaitre P; Seurinck R; Mori A; Grieco GE; Bissenova S; Ellis D; Caluwaerts S; Rottiers P; Vandamme N; Mathieu C; Dotta F; Gysemans C; Sebastiani G
    Diabetes; 2023 Oct; 72(10):1470-1482. PubMed ID: 37494666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral administration of Lactococcus lactis delivered heat shock protein 65 attenuates atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Jing H; Yong L; Haiyan L; Yanjun M; Yun X; Yu Z; Taiming L; Rongyue C; Liang J; Jie W; Li Z; Jingjing L
    Vaccine; 2011 May; 29(24):4102-9. PubMed ID: 21497632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased neutrophil elastase and proteinase 3 and augmented NETosis are closely associated with β-cell autoimmunity in patients with type 1 diabetes.
    Wang Y; Xiao Y; Zhong L; Ye D; Zhang J; Tu Y; Bornstein SR; Zhou Z; Lam KS; Xu A
    Diabetes; 2014 Dec; 63(12):4239-48. PubMed ID: 25092677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and purification of staphylococcal nuclease in Lactococcus lactis using a new expression-secretion system and a pH-regulated mini-reactor.
    Trémillon N; Issaly N; Mozo J; Duvignau T; Ginisty H; Devic E; Poquet I
    Microb Cell Fact; 2010 May; 9():37. PubMed ID: 20492646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Contribution of Neutrophils and NETs to the Development of Type 1 Diabetes.
    Petrelli A; Popp SK; Fukuda R; Parish CR; Bosi E; Simeonovic CJ
    Front Immunol; 2022; 13():930553. PubMed ID: 35874740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretion of biologically active pancreatitis-associated protein I (PAP) by genetically modified dairy Lactococcus lactis NZ9000 in the prevention of intestinal mucositis.
    Carvalho RD; Breyner N; Menezes-Garcia Z; Rodrigues NM; Lemos L; Maioli TU; da Gloria Souza D; Carmona D; de Faria AM; Langella P; Chatel JM; Bermúdez-Humarán LG; Figueiredo HC; Azevedo V; de Azevedo MS
    Microb Cell Fact; 2017 Feb; 16(1):27. PubMed ID: 28193209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.